SPOTLIGHT: Tapestry sheds staff

Tapestry Pharmaceuticals says it will lay off 14 workers, 28 percent of its staff, as it concentrates all of its efforts on advancing TPI 287 for prostate and pancreatic cancer. Boulder, CO-based Tapestry says it can save $11 million in the strategic shift. Release

Suggested Articles

After delivering a "positive surprise" in December, Biogen is painting a fuller picture of its lupus drug.

A new CRISPR technique neutralizes SARS-CoV-2 by scrambling the virus' genetic code. It could prove useful for fighting other viruses, like influenza.

The deal, which follows a bidding war with AcelRx, gives Melinta another approved antibiotic and potentially complementary R&D expertise.